Login
Navigate Fool.com
Will PETX beat
the market?

ARATANA THERAPEUTICS (NASDAQ: PETX)

Community Rating: Unrated

12.56 -0.38 (-2.94%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.01
Previous Close $12.94
Daily Range $12.53 - $13.33
52-Week Range $8.07 - $29.32
Market Cap $369.9M
P/E Ratio 3.24
Dividend (Yield) $0.00 (0.0%)
Volume 145,413
Average Daily Volume 246,880
Current FY EPS -$1.56

How do you think PETX
will perform against the market?

Top PETX Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Wednesday’s Top Biotech Stories: Roche, Zogenix, and Aratana Therapeutics

Roche, Zogenix, and Aratana Therapeutics could be the top health care stocks to watch this Wednesday morning. Here’s why.

Sector Update: Healthcare Shares Mixed Pre-Market; Aratana Files for Product License For Cancer Immu

Sector Update: Healthcare Shares Mixed Pre-Market; Aratana Files for Product License For Cancer Immunotherapy

Sector Update: Healthcare

Sector Update: Shares Flat Pre-Market; TG Therapeutics Sinks 5% on Preliminary Clinical Results

Sector Update: Healthcare Healthcare

3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics

Last week's three worst performing biotech stocks.

Here Are Some Ways To Get In On A Booming Market For Pet Stocks

3 Big Movers in Cancer Care -- Ariad Pharmaceuticals, Galena Biopharma, and Aratana Therapeutics

Ariad Pharmaceuticals (NASDAQ: ARIA), Galena Biopharma (NASDAQ: GALE), and Aratana Therapeutics (NASDAQ: PETX) have all served up a roller-coaster ride for shareholders in 2014.

Despite Dilution, Aratana Therapeutics Can Keep Climbing

Aratana Therapeutics recently announced conditional approval by the USDA of its lymphoma treatment for dogs, a big potential revenue driver.

3 Stocks You Must Follow This Morning: Cell Therapeutics Inc., Aratana Therapeutics Inc., and Therap

Cell Therapeutics, Aratana Therapeutics, and TherapeuticsMD could be three health care stocks worth watching today. Here’s why.

See More PETX News...

Sector

Industry

ARATANA THERAPEUTICS (PETX) Description

ARATANA THERAPEUTICS INC COM USD0.001 Website: http://www.aratana.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks